NICPB joins an European collaboration for developing vaccine adjuvants

Dr. Olesja Bondarenko from the Laboratory of Environmental Toxicology has joined the European Network of Vaccine Adjuvants (ENOVA), which brings together European experts and stakeholders working in different areas of adjuvant and vaccine research and development. ENOVA is funded by COST through the EU Framework Programme Horizon 2020 and is coordinated by the Vaccine Formulation Institute.

The goals of the network are to facilitate communication and to exchange of information on adjuvants and vaccine formulation among its members, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants and vaccines. Currently organizations from 28 countries joined ENOVA.

Please visit the project website for further information:

Contact Information